QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

MEDP

QT71Medpace Holdings, Inc.
NASDAQ·Healthcare·Medical - Diagnostics & Research·USA
Latest market price
460.20
+3.11+0.68%
OverviewShort InterestFilings
MEDPQT71Medpace Holdings, Inc.·NASDAQ
OverviewShort InterestFilings
460.20+0.68%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06NTRA+2.19%$231.41IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44
Snapshot
Index-P/E28.24EPS (ttm)15.92
Insider Own46.38%
Shs Outstand28.56M
Perf Week-3.13%
Market Cap13.05BForward P/E25.05EPS next Y18.37Insider Trans0.47%Shs Float-Perf Month9.59%
Enterprise Value12.52BPEG1.40EPS next Q3.98Inst Own-Short Float-Perf Quarter-0.16%
Income462.12MP/S4.87EPS this Y6.69%Inst Trans-Short Ratio-Perf Half Y-17.64%
Sales2.68BP/B21.73EPS next Y8.17%ROA21.62%Short Interest-Perf YTD-18.06%
Book/sh20.94P/C17.59EPS next 5Y9.02%ROE120.89%52W High628.95 -26.83%Perf Year54.47%
Cash/sh22.86P/FCF17.69EPS past 3/5Y-ROIC57.77%52W Low294.08 56.49%Perf 3Y-
Dividend Est.-EV/EBITDA20.88Sales past 3/5Y20.11% 22.26%Gross Margin29.07%Volatility2.23% 2.55%Perf 5Y-
Dividend TTM-EV/Sales4.68EPS Y/Y TTM25.97%Oper. Margin21.02%ATR (14)15.31Perf 10Y-
Dividend Ex-Date-Quick Ratio0.85Sales Y/Y TTM26.98%Profit Margin17.19%RSI (14)55.11Recom2.86
Dividend Gr. 3/5Y-Current Ratio0.85EPS Q/Q16.62%SMA201.64%Beta1.02Target Price498.86
Payout0.00%Debt/Eq0.20Sales Q/Q26.48%SMA502.05%Rel Volume1.25Prev Close457.09
Employees5,900LT Debt/Eq0.50EarningsJul 20SMA200-10.20%Avg Volume377.99KPrice460.20
IPO DateAug 11, 2016Option/ShortYes / YesEPS/Sales Surpr.14.44% 1.29%Net Debt/EBITDA-0.88Volume472,665Change0.68%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-24-26ReiteratedRobert W. Baird$565 → $477
Apr-24-26ReiteratedBarclaysEqual Weight$500 → $450
Apr-24-26ReiteratedRBC CapitalOutperform$484
Apr-24-26ReiteratedBMO CapitalMarket Perform$460 → $400
Mar-06-26UpgradeBarclaysUnderweight → Equal Weight$525 → $500
Feb-18-26UpgradeTD CowenSell → Hold
Feb-13-26UpgradeJefferiesHold → Buy$345 → $560
Feb-11-26ReiteratedTruist Financial$555 → $539
Feb-11-26ReiteratedMizuho Securities$660 → $582
Feb-11-26ReiteratedBMO Capital$600 → $460
Latest News
Jun-18-26
Jun-18-2612:46PM
What Makes Medpace Holdings (MEDP) an Investment Bet?Yahoo
Jun-16-26
Jun-16-2610:15PM
Medpace (MEDP) Suffers a Larger Drop Than the General Market: Key InsightsYahoo
08:23PM
Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026Yahoo
12:17AM
Medpace (MEDP) Stock Weighing Modest Undervaluation Against Rich P/E And Mixed MomentumYahoo
Jun-15-26
Jun-15-2612:12PM
1 Profitable Stock to Consider Right Now and 2 We Brush OffYahoo
Jun-12-26
Jun-12-2603:40PM
CON vs. MEDP: Which Stock Is the Better Value Option?Yahoo
03:24PM
Madison Small Cap Fund Increased Medpace Holdings (MEDP), Downplaying AI FearsYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,6782,5302,109
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1,8991,7701,453
Gross Profit778761656
Selling, General and Administrative Excl. Other188198180
Research and Development
000
Other Operating Expense282829
Operating Income563535447
Interest Expense000
Unusual Expense
———
Non-Operating Income (Expense)-9-7-29
Net Income Before Taxes573542476
Income Taxes1129172
Consolidated Net Income460451404
Net Income From Continuing Operations460451404
Net Income460451404
EPS (Recurring)16.2415.6413.06
EPS (Basic, Before Extraordinaries)16.2415.6413.06
EPS (Diluted)15.9215.2812.63
EBITDA600571505
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio28.9136.76—
Price To Sales Ratio4.816.44—
Gross Margin29.0530.0831.10
Operating Margin21.0221.1521.19
Net Margin17.1817.8319.16
Shares Outstanding282931
Market Capitalization12,88616,288—
Operating Lease Expense
———
Insider Trading Volume
$490.97$460.63$430.30$399.96$369.62● Close Price0.00M47.89M95.79M143.68M191.57MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
EWALD STEPHEN PGeneral Counsel & Corp. Secy.May 28 '26Option Exercise138.8732,6984,540,77236,692Jun 01 12:00 AM
EWALD STEPHEN PGeneral Counsel & Corp. Secy.May 28 '26Sale450.0016,3497,357,05020,343Jun 01 12:00 AM
EWALD STEPHEN PGeneral Counsel & Corp. Secy.Apr 24 '26Option Exercise138.877,000972,09020,343Apr 28 12:00 AM
Brady Kevin M.CFO & TreasurerApr 24 '26Option Exercise138.8714,0001,944,18012,830Apr 28 12:00 AM
McCarthy Cornelius P. IIIDirectorMar 31 '26Option Exercise0.0058010,324Apr 02 12:00 AM
Kraft Robert O.DirectorMar 31 '26Option Exercise0.00660922Apr 02 12:00 AM
Carley Brian TDirectorMar 31 '26Option Exercise0.0072032,789Apr 02 12:00 AM
BURWIG SUSAN EExec. VP, OperationsMar 18 '26Option Exercise166.7324,0004,001,52070,484Mar 19 12:00 AM
GEIGER JESSE JPresidentMar 17 '26Option Exercise138.8763,4148,806,30246,707Mar 19 12:00 AM
GEIGER JESSE JPresidentMar 17 '26Sale455.3031,70714,436,19715,000Mar 19 12:00 AM
EWALD STEPHEN PGeneral Counsel & Corp. Secy.Feb 17 '26Option Exercise138.877,000972,09019,849Feb 18 12:00 AM
Carley Brian TDirectorFeb 13 '26Option Exercise54.9912,944711,79032,753Feb 17 12:00 AM
BURWIG SUSAN EExec. VP, OperationsFeb 13 '26Option Exercise107.9321,9682,371,00658,484Feb 17 12:00 AM
McCarthy Cornelius P. IIIDirectorDec 31 '25Option Exercise0.0098010,295Jan 05 12:00 AM
Kraft Robert O.DirectorDec 31 '25Option Exercise0.001120889Jan 05 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR